Guy Donati
Overview
Explore the profile of Guy Donati including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
228
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Turgut F, Somfai G, Tappeiner C, Hatz K, Mantel I, Ambresin A, et al.
Pharmaceuticals (Basel)
. 2024 Sep;
17(9).
PMID: 39338397
Background/objectives: Diabetic macular edema (DME) is a significant cause of visual impairment, often treated with anti-vascular endothelial growth factor (anti-VEGF) agents. However, some patients do not respond adequately to this...
2.
Garweg J, Pietzuch M, Mantel I, Ambresin A, Tappeiner C, Nagyova D, et al.
J Ocul Pharmacol Ther
. 2024 Apr;
40(3):199-200.
PMID: 38569165
No abstract available.
3.
Pietzuch M, Mantel I, Ambresin A, Tappeiner C, Nagyova D, Donati G, et al.
J Ocul Pharmacol Ther
. 2023 Dec;
40(6):361-369.
PMID: 38117666
To assess the impact of switching to, or adding, an intravitreal dexamethasone implant (Dex; Ozurdex) in anti-vascular endothelial growth factor (VEGF) therapy on disease stability and treatment intervals in eyes...
4.
Munk M, Somfai G, Smet M, Donati G, Menke M, Garweg J, et al.
Int J Mol Sci
. 2022 Jul;
23(14).
PMID: 35886930
This work aims to summarize predictive biomarkers to guide treatment choice in DME. Intravitreal anti-VEGF is considered the gold standard treatment for centers involving DME, while intravitreal steroid treatment has...
5.
Mendrinos E, Mangioris G, Papadopoulou D, Donati G, Pournaras C
Acta Ophthalmol
. 2013 Apr;
91(3):e184-90.
PMID: 23590391
Purpose: To study the effect of intravitreal (IVT) ranibizumab on the retinal arteriolar diameter in patients with neovascular age-related macular degeneration (AMD). Methods: Ten eyes of 10 patients with previously...
6.
Mendrinos E, Mangioris G, Papadopoulou D, Donati G, Pournaras C
Invest Ophthalmol Vis Sci
. 2009 Oct;
PMID: 19797227
Withdrawn at the request of the author.
7.
Papadopoulou D, Mendrinos E, Mangioris G, Donati G, Pournaras C
Ophthalmology
. 2009 Jun;
116(9):1755-61.
PMID: 19560206
Objective: To study the effect of intravitreal (IVT) ranibizumab (Lucentis; Genentech, Inc, San Francisco, CA) on the retinal arteriolar diameter in patients with neovascular age-related macular degeneration (AMD). Design: Prospective...
8.
Mendrinos E, Donati G, Pournaras C
Acta Ophthalmol
. 2008 Nov;
87(6):683-4.
PMID: 19021597
No abstract available.
9.
Mendrinos E, Pilly B, Baglivo E, Donati G, Safran A, Pournaras C
Acta Ophthalmol
. 2008 Jul;
87(4):473-5.
PMID: 18652579
No abstract available.
10.
Donati G, Kapetanios A, Dubois-Dauphin M, Pournaras C
Acta Ophthalmol
. 2008 May;
86(3):302-6.
PMID: 18494728
Purpose: Acute brain ischaemia (stroke) causes a central area of coagulation necrosis. Peripheral to it and after a few hours, apoptosis causes neurons throughout the entire area to die progressively....